Antivenom crisis in South Africa
Key Questions
What is causing the antivenom shortage in South Africa?
The shortage stems from challenges in production by SAIMR/SAVP, including a shift to the PANAF polyvalent antivenom which has higher allergic reaction rates, and the lack of any fully registered alternative. This situation poses risks for venomous snakebite treatment and conservation efforts.
How has the snake handler survived multiple black mamba bites?
The handler built up venom tolerance through repeated exposure, allowing survival after bites that would typically be fatal. His experiences are contributing to research on a potential universal antivenom, which may soon be tested on pets.
Is there a connection between South African antivenom issues and global snake venom research?
Yes, efforts to address shortages and develop better antivenoms, such as through tolerance studies and polyvalent options, align with international work like that on Brazil's Snake Island for pharmaceutical extraction. These advances are critical for keepers and conservation worldwide.
Deep dive into shortage of antivenom, history of SAIMR/SAVP production, shift to PANAF polyvalent, allergic reaction rates, no fully registered alternative. Story of handler surviving repeated black mamba bites after building venom tolerance; his work contributes to a universal antivenom tested on pets soon. Critical for venomous keepers and conservation.